Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ————— — Research & development ————— — Operating income 3.35 B2.13 B1.08 B-3.65 B2.93 B 2.48 B Non-Operating Income, Total 310 M366 M475 M384 M307 M 1.53 B Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 310 M366 M475 M384 M307 M 1.53 B Unusual income/expense ————— — Pretax income 3.57 B2.38 B1.42 B-4.25 B3.35 B 2.89 B Equity in earnings 303 M91 M290 M-500 M266 M 147 M Taxes 719 M481 M127 M-989 M642 M 261 M Non-controlling/minority interest 69 M-1 M-35 M50 M78 M 92 M After tax other income/expense ————— — Net income before discontinued operations 2.78 B1.9 B1.33 B-3.31 B2.63 B 2.54 B Discontinued operations ————— — Net income 2.78 B1.9 B1.33 B-3.31 B2.63 B 2.54 B Dilution adjustment 00000 0 Preferred dividends -577 M30 M30 M34 M13 M 107 M Diluted net income available to common stockholders 3.36 B1.86 B1.3 B-3.34 B2.61 B 2.43 B Basic earnings per share (Basic EPS) 3.41.941.37-3.382.87 2.8 Diluted earnings per share (Diluted EPS) 3.351.911.35-3.342.82 2.74 Average basic shares outstanding 988 M963 M944 M955 M911 M — Diluted shares outstanding 1 B976 M964 M973 M926 M — EBITDA 6.29 B5.15 B4.14 B-692 M5.93 B 14.53 B EBIT 3.35 B2.13 B1.08 B-3.65 B2.93 B 2.48 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 2.93 B3.03 B3.07 B2.95 B3 B 12.05 B